37 companies

AbCellera Biologics

Market Cap: US$3.7b

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

New

ABCL

US$11.38

7D

21.8%

1Y

143.7%

Sino BiologicalInc

Market Cap: CN¥17.0b

Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.

301047

CN¥139.49

7D

22.8%

1Y

88.4%

Lin BioScience

Market Cap: NT$78.4b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

6696

NT$947.00

7D

31.5%

1Y

499.4%

AcrobiosystemsLtd

Market Cap: CN¥16.0b

Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.

New

301080

CN¥95.88

7D

23.4%

1Y

71.4%

Eton Pharmaceuticals

Market Cap: US$1.7b

A pharmaceutical company, focuses on developing and commercializing treatments for rare diseases.

New

ETON

US$58.86

7D

34.8%

1Y

259.6%

HARBIN GLORIA PHARMACEUTICALS

Market Cap: CN¥11.1b

Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally.

New

002437

CN¥4.98

7D

45.2%

1Y

33.5%

Marksans Pharma

Market Cap: ₹150.2b

Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.

New

MARKSANS

₹331.45

7D

22.1%

1Y

79.9%

Omeros

Market Cap: US$1.2b

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

New

OMER

US$17.19

7D

26.2%

1Y

306.9%

Anhui Wanbang Pharmaceutical TechnologyLtd

Market Cap: CN¥7.9b

Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

New

301520

CN¥85.06

7D

45.0%

1Y

155.8%

Boji Medical TechnologyLtd

Market Cap: CN¥6.7b

Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.

New

300404

CN¥17.60

7D

56.7%

1Y

60.6%

Climb Bio

Market Cap: US$937.9m

A clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with immune-mediated diseases.

New

CLYM

US$16.33

7D

20.6%

1Y

673.9%

Gansu Longshenrongfa Pharmaceutical IndustryLTD

Market Cap: CN¥6.1b

Researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.

New

300534

CN¥20.23

7D

27.4%

1Y

82.7%

Xinjiang Bai Hua Cun Pharma TechLtd

Market Cap: CN¥5.4b

Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

600721

CN¥14.02

7D

21.0%

1Y

59.7%

Novoprotein Scientific

Market Cap: CN¥4.8b

Researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.

New

688137

CN¥68.43

7D

24.6%

1Y

46.2%

Assembly Biosciences

Market Cap: US$670.9m

A biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide.

New

ASMB

US$32.95

7D

23.2%

1Y

27.9%

Oncolys BioPharma

Market Cap: JP¥102.2b

Engages in the research, development, manufacturing, sale, and import of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the United States, and Asia.

New

4588

JP¥3,490.00

7D

22.5%

1Y

372.3%

Shanghai Kai Kai Industry

Market Cap: CN¥3.7b

Engages in the wholesale and retail of pharmaceutical products in China.

New

600272

CN¥19.03

7D

33.4%

1Y

39.3%

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥3.6b

Operates as a pharmaceutical manufacturing holding investment company in China.

New

600613

CN¥7.05

7D

35.8%

1Y

2.2%

Xinjiang Tianshan Animal Husbandry Bio-engineering

Market Cap: CN¥2.6b

Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.

New

300313

CN¥10.73

7D

27.0%

1Y

1.7%

Camp4 Therapeutics

Market Cap: US$341.4m

A clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases.

New

CAMP

US$5.44

7D

28.9%

1Y

192.5%

Ind-Swift Laboratories

Market Cap: ₹27.2b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.

New

INDSWFTLAB

₹313.02

7D

31.9%

1Y

211.5%

Cardiol Therapeutics

Market Cap: CA$289.3m

A clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

New

CRDL

CA$2.51

7D

21.8%

1Y

48.5%

Cue Biopharma

Market Cap: US$143.7m

A clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders.

New

CUE

US$34.20

7D

31.0%

1Y

39.2%

RenovoRx

Market Cap: US$63.1m

A clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment.

New

RNXT

US$1.40

7D

20.7%

1Y

48.9%

Apollomics

Market Cap: US$51.4m

A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.

New

APLM

US$23.40

7D

31.1%

1Y

310.5%

Sareum Holdings

Market Cap: UK£36.7m

A clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases.

New

SAR

UK£0.28

7D

21.7%

1Y

21.7%

Bilcare

Market Cap: ₹2.3b

Provides pharmaceutical packaging research solutions in India and internationally.

New

526853

₹92.54

7D

52.3%

1Y

40.2%

Aton

Market Cap: €10.4m

Operates as a bioscience company in France.

New

ALTAO

€0.017

7D

46.6%

1Y

107.3%

Brainstorm Cell Therapeutics

Market Cap: US$10.9m

A biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases.

New

BCLI

US$0.99

7D

25.3%

1Y

59.7%

Revive Therapeutics

Market Cap: CA$13.1m

A life sciences company, focuses on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders.

New

RVV

CA$0.03

7D

20.0%

1Y

50.0%

Hepion Pharmaceuticals

Market Cap: US$6.7m

A biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States.

New

HEPA

US$0.075

7D

25.0%

1Y

15.7%

Dannex Ayrton Starwin

Market Cap: GH₵68.7m

Engages in the manufacturing, importing, and sale of pharmaceutical products in Ghana.

New

DASPHARMA

GH₵0.81

7D

42.1%

1Y

113.2%

Vaxxinity

Market Cap: US$3.2m

A biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.

New

VAXX

US$0.025

7D

25,400.0%

1Y

25,400.0%

Enzolytics

Market Cap: US$2.9m

A drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

New

ENZC

US$0.0006

7D

20.0%

1Y

0%

GB Sciences

Market Cap: US$211.8k

A plant-based research and biopharmaceutical drug development company.

New

GBLX

US$0.0004

7D

33.3%

1Y

100.0%

Hero Technologies

Market Cap: US$56.4k

Operates as an early-stage cannabis company.

New

HENC

US$0.0001

7D

9,900.0%

1Y

0%

Page 1 of 2